Pfarr Nicole, Musholt Thomas J, Musholt Petra B, Brzezinska Rita, Pohlenz Joachim
Department of Pediatrics, Johannes Gutenberg University Medical School, Mainz, Germany.
Clin Endocrinol (Oxf). 2006 May;64(5):514-8. doi: 10.1111/j.1365-2265.2006.02500.x.
Congenital primary hypothyroidism occurs in 1 of 4000 births. Whereas the majority of the cases are due to developmental defects of the thyroid gland, 20% carry a defect in thyroid hormonogenesis. We report a Turkish boy who had goitrous hypothyroidism due to a mutation in the thyroid peroxidase (TPO) gene.
The TPO gene was sequenced directly from genomic DNA and cDNA which was transcribed from three RNA samples harvested from different parts of the patient's excised thyroid gland. Patient The boy was thyroidectomized because of continuing growth of his thyroid gland and development of multiple nodes suspected of malignancy by ultrasound examination. Histopathological examination verified a dyshormonogenetic goiter with multiple follicular adenomas.
The patient had a novel homozygous 10-bp deletion of the TPO gene at position 2812 in exon 16. This frame shift mutation results in a severely altered intracellular part of the protein. The deletion identified in leucocyte DNA was also found in thyroid tissue cDNA - so that instability of the transcript or a splicing defect was excluded. Both unaffected parents were heterozygous carriers of the mutation whereas 50 healthy individuals of the same ethnic background did not harbour the mutation.
The identified TPO gene deletion is the first mutation coding for an inactive TPO molecule, which has a severely altered intracellular segment. Because the most likely reason for the enlarging goiter was poor compliance of the patient, this report underlines the importance of a careful and regular follow-up of patients with dyshormonogenesis.
先天性原发性甲状腺功能减退症的发病率为4000例活产中有1例。虽然大多数病例是由于甲状腺发育缺陷,但20%的病例存在甲状腺激素合成缺陷。我们报告一名患有甲状腺肿性甲状腺功能减退症的土耳其男孩,其病因是甲状腺过氧化物酶(TPO)基因突变。
直接从基因组DNA和cDNA对TPO基因进行测序,cDNA是从患者切除的甲状腺不同部位采集的三个RNA样本转录而来。患者:该男孩因甲状腺持续生长以及超声检查怀疑多个结节有恶变而接受了甲状腺切除术。组织病理学检查证实为伴有多个滤泡性腺瘤的激素合成障碍性甲状腺肿。
患者在第16外显子的2812位有一个新的TPO基因纯合10碱基缺失。这种移码突变导致蛋白质的细胞内部分严重改变。在白细胞DNA中发现的缺失也在甲状腺组织cDNA中发现,因此排除了转录本不稳定或剪接缺陷。父母双方均未受影响,是该突变的杂合携带者,而50名相同种族背景的健康个体未携带该突变。
所鉴定的TPO基因缺失是第一个编码无活性TPO分子的突变,该分子的细胞内片段严重改变。由于甲状腺肿增大的最可能原因是患者依从性差,本报告强调了对激素合成障碍患者进行仔细定期随访的重要性。